ArticleClinical and translational medicine2026
miR-941 in extracellular vesicles confers anlotinib resistance via Keap1/Nrf2 axis and represents a therapeutic target in non-small cell lung cancer.
Aimi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.